The Australasian Professional Society on Alcohol and other Drugs

Advocacy Award Information

APSAD Awards Banner

NEW AWARD CATEGORY FOR 2021

As part of the Society's 40th Anniversary celebrations, we are announcing a new Award Category. The Advocacy Award will recognise the outstanding impact by an individual or a team in the alcohol, tobacco, and other drugs sector who works in the policy and/or advocacy area.

This is the first APSAD Award open to teams and the recipient of the 2021 Advocacy Award will have the opportunity to hold an Advocacy Workshop at the 2021 APSAD Brisbane Conference.

Details for the new Advocacy Award:

The Advocacy Award recognises the outstanding impact by an individual or a team in the alcohol, tobacco, and other drugs sector who works in the policy and/or advocacy area.

Eligibility

  • Any individual or team who has made an outstanding impact in policy and/or advocacy in the alcohol, tobacco and other drugs field, and can demonstrate one or more of the achievements below;
  • Positive advancement in the understanding of alcohol, tobacco and other drugs issues in a given community or population group, or
  • Advocacy for an advancement that is in the public interest (public health or welfare and/or criminal justice), evidence based (evidence that it will work as intended), and has a focus on reducing drug related harm, or
  • Positive policy change for the alcohol, tobacco and other drugs field. Change could occur in the following areas but are not limited to; legislative, government, and community, or
  • Strategy formation, e.g. strategic thinking, coalition formation, government liaison, key messaging.

Selection Criteria

Evidence of the impact made in the alcohol, tobacco and other drugs field. The nomination should clearly describe the achievements to be honoured, the scope and depth of the impact, and the processes used by the nominee, including for instance strategy formation and the use of evidence to underpin the advocacy/policy.

Further Details:

  • Nominations can be for any individual or team that meets the criteria for the Advocacy Award category.
  • APSAD Membership is not a prerequisite, nor is it of any advantage or disadvantage during the nomination process.
  • The nominator must be a current (financial) member of APSAD. Any member can nominate across multiple Award Categories.
  • Nominations close 7 September 2021, the Award recipient is announced in October and is given the opportunity to organise a workshop at the 40th APSAD Conference in Brisbane.
  • The Recipients for all Award Categories are announced at the official Awards Ceremony held during the 40th APSAD Conference in Brisbane on 8-10 November.

Head to the Awards page for the Information pack and nomination form.

 

2020 Award highlights

With the cancellation of this year's APSAD conference due to COVID-19 the annual APSAD Awards ceremony was held online.

APSAD President Professor Michael Farrell presented the 2020 APSAD Awards for Excellence in Science, Research and Practice at the special online ceremony. The six recipients of the APSAD Awards are recognised as having made an outstanding contribution to reducing the harms associated with alcohol and other drug use in Australasia.

2020 APSAD AWARD WINNERS

Senior scientist
Senior Scientist Award Robert Ali
 Mid Career Mentor Award winners
L to R: Mid Career Award
Suzanne Nielsen &
Mentor Award Paul Dietze
First Peoples winner Robert Assan photo
First Peoples Award 
Robert Assan 
Clinician Award winnerClinician Award 
Anthony Gill
Early career winner Cheneal PuljevicEarly Career Award
Cheneal Puljević

Senior Scientist Award A/Prof Robert Ali

Associate Professor Robert Ali ( MBBS FAFPHM, FAChAM DPH) is a public health physician and specialist in addiction medicine. Until October 2016 he was the clinical director of Drug & Alcohol Services South Australia; a role he held for 30 years. Currently he is a Senior Research Fellow at the University of Adelaide. Robert is a member of the Australian National Advisory Council on Alcohol and Drugs, member of the Cochrane Alcohol and Drug Group editorial board and the WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems.

The Senior Scientist Award is for a scientist who has made an outstanding contribution to the field of substance use.

Mid Career Award A/Prof Suzanne Nielsen
Associate Professor Suzanne Nielsen (BPharmSc[Hons] PhD MPS) is the Deputy Director of the Monash Addiction Research Centre in Melbourne, and is a current NHMRC Career Development Fellow. Suzi has been a registered pharmacist for over 20 years with clinical experience in the treatment of substance use disorders includes in specialist drug treatment and community-based alcohol and drug treatment settings in Australia and the United Kingdom. She has published over 135 scientific publications and given over 170 national and international conference presentations on her research, which has led to a greater understanding of how to identify and respond to prescription and over-the-counter drug-related problems. Her recent work has a focus on reducing opioid-related harm and overdose prevention. Suzi has worked with Australian state and federal governments to reduce opioid-related and other drug harm.

The Mid Career Award is for significant contribution in the alcohol and other drug field.


Early Career Award Dr Cheneal Puljević

Dr Cheneal Puljev is a Research Fellow at the Centre for Health Services Research and the School of Public Health at the University of Queensland. At the Centre for Health Services Research she is the Program Manager for the Global Substance Use and Mental Health unit, where she conducts and manages a number of research projects related to substance use, including the Queensland evaluation of the Tackling Alcohol-Fuelled Violence Policy (QUANTEM), and several projects using data from the Global Drug Survey. At the School of Public Health, she is the co-coordinator of the CARP smoking cessation trial, and contributes to projects promoting smoking cessation among priority populations. Her primary research interest is smoking cessation among disadvantaged populations, with her PhD (completed in 2018) and current UQ Early Career Researcher Grant focusing on this topic. (https://researchers.uq.edu.au/researcher/22250)

The Early Career Award is for excellence in research relative to career opportunities.

Mentor Award Prof Paul Dietze

Professor Paul Dietze is one of Australia’s leading alcohol and other drug epidemiologists with a significant national, and emerging international profile. He is an NHMRC Senior Research Fellow and a past ARC Future Fellow and VicHealth Public Health Research Fellow. With more than 20 years’ experience and an outstanding track record, his work has established internationally innovative surveillance systems and applied research designs that break new ground in the public health research into alcohol and other drug use and related harms in Australia. He has produced more than 290 journal articles along with many other reports of significant impact that have changed practice in the area of alcohol and other drugs in this country. During the course of his research career he has received more than $20 million of research funding. (https://www.burnet.edu.au/people/174_paul_dietze)

The Mentor Award recognises an individual who has made an important contribution to mentoring and supporting the career development of clinicians, researchers or students.

First Peoples Award Robert Assan

I am both Aboriginal and Torres Strait Islander. I was born in the Northern Territory, but my cultural background is from Thursday Island.

Training has been a big part of my work. And it gives me great satisfaction – working with health workers and seeing them come along in their ability to help individuals and families around alcohol and drugs. I have been able to offer training and support to Aboriginal and Torres Strait Islander workers around Australia, and to many other staff. The training helps them work with Aboriginal or Torres Strait Islander people with alcohol or drug problems. I have also worked with individuals and communities, in the Northern Territory and in Queensland, to help them rethink their alcohol or drug use.

My current work involves both training and support of health workers, and one-to-one work with adolescents. This work is at the Cleveland Youth Detention Centre in Townsville. I like that sense of planting the seed that leads to change later on. You don’t always see the results straight away, but the seed is there. The young people are able to use that information that you’ve given them. I equip people with knowledge and skills and insight that can help them in life.

Recognises an individual that has made an important contribution to the advancement of the health of Aboriginal, Torres Strait Islander and Māori peoples.

Clinician Award Dr Anthony Gill

Dr Anthony (Tony) Gill is an Addiction Medicine Specialist who has worked in the Drug and Alcohol field for around 30 years. He has worked as a clinician and clinical leader primarily. He has held various Drug and Alcohol Clinical Director positions in NSW Local Health Districts and in the past in the NSW Ministry of Health. He is presently a Senior Staff Specialist in the Alcohol and Drug Service at St Vincent’s Hospital Sydney, and Chief Addiction Medicine Specialist in the NSW Ministry of Health. His interests in drug and alcohol include teaching and clinical service development and redesign, and he has worked extensively with general practitioners to enhance their activities in drug and alcohol.

Recognises excellence and leadership in clinical practice in the field of substance use in any discipline.

 

2018 APSAD Award Highlights

2018 APSAD Award Winners announced 

The APSAD Conference Dinner and Awards was held at Maritime Room Auckland. The recipients of the APSAD Awards are recognised as having made an outstanding contribution to reducing the harms associated with alcohol and other drug use in Australasia. It is a special experience to formally acknowledge the dedication of our peers and celebrate the quality of their work. 

 Award winners group photo reduce size
Left to Right: APSAD President Anthony (Tony) Gill; Gillian Gould; Nicholas Lintzeris; Billie Bonevski
 
Early Career Award Winner Gillian Gould
 
A/Prof Gillian Gould has made a highly significant and unique contribution to AOD research into Indigenous smoking cessation as an early career researcher, obtaining her PhD in 2015. Gould’s PhD by publication was an outstanding contribution to understanding how anti-tobacco messages need to be targeted better to Indigenous communities and in particular, to pregnant smokers. Since moving to University of Newcastle (UON) in 2015, Gould achieved an extremely impressive track record by being awarded $5.5million in funding, and since the start of her PhD, published 39 peer-reviewed papers. She is currently funded by two prestigious research fellowships from NHMRC and Cancer Institute NSW (CINSW) until the end of 2018, and has already secured a NHMRC Translating Research Into Practice Fellowship co-funded by CINSW ($100,000) commencing in 2019. Gould established and leads a new research stream in Indigenous smoking for the School of Medicine and Public Health at UON on culturally competent approaches in the vital area of smoking cessation during pregnancy. Gould is highly effective at combining her extensive clinical experience as a general practitioner, a Tobacco Treatment Specialist and public health researcher to advance knowledge and find pragmatic solutions in this important area. She has worked intensively at a community level with Aboriginal people for several years to build trusted relationships, which allows her to co-develop many Indigenous tobacco programs.
 
The Early Career Award is for excellence in research relative to career opportunities.
 
 
Senior Scientist Award Winner Nicholas Lintzeris 
 
Prof Lintzeris has been highly active for over a quarter of a century in drug and alcohol clinical service delivery, research, professional education and policy developments in Australia and has been a key leader in many important developments in our field across this time. He is Foundation Fellow of the Chapter of Addiction Medicine in the Royal Australasian College of Physicians. He has an international reputation as an expert in the drug and alcohol field with interests across opioids, cannabinoids, stimulants, alcohol, benzodiazepines and ‘new’ psychoactive substances. Prof Lintzeris graduated from the University of Tasmania (MBBS, B Med Sci) then worked in the public drug and alcohol sector in Victoria. He helped establish Turning Point Alcohol and Drug Centre as a lead NGO in the field in Victoria in the 1990s. He subsequently has led drug and alcohol services in South West Sydney, Sydney and South East Sydney Local Health Districts in NSW including important clinical service re-design and innovation. He has been Chief Addiction Medicine specialist for NSW Health, helping develop and implement a clinical outcomes and quality improvement process across public drug and alcohol services throughout NSW that is currently being implemented. He has been highly active in policy development for over two decades, sitting on numerous state and national committees and publishing multiple clinical guidelines in the field. Professor Lintzeris' PhD examined the use of buprenorphine in inpatient and outpatient opiate withdrawal and provided important data to enable the safe and effective rapid uptake of buprenorphine for withdrawal treatment in Australia. He has contributed to state and national opiate treatment guidelines in addiction treatment and played a lead role in the current national and NSW opiate treatment clinical guidelines. He was awarded the Neil Hamilton Fairley Clinical Research Post-doctoral Fellowship by the NH&MRC and led a pivotal RCT of injectable heroin treatment through the National Addiction Centre in the UK as well as psychopharmacological studies of opiates and benzodiazepines.
 
The Senior Scientist Award is for a scientist who has made an outstanding contribution to the field of substance use and misuse.
 
Mentor Award Winner Billie Bonevski 
 
Professor Billie Bonevski is a health behaviour scientist and Professor at the University of Newcastle (UON), Faculty of Health and Medicine. She is a NHMRC Career Development Fellow (CDF Level 2: 2014-2018) and the recipient of the prestigious Faculty of Health and Medicine’s Gladys M Brawn Research Award. Bonevski completed a scholarship-supported PhD at the University of Newcastle, in the Discipline of Behavioural Science in Relation to Medicine after gaining a Psychology Honours degree (1st Class with WH Ward Prize for Best Applied Thesis). Immediately following her PhD she completed a World Health Organisation-sponsored postdoctoral travel fellowship with Cancer Research UK and the Cochrane Collaboration’s Tobacco Addiction Review Group, both based at Oxford University.

"She is a champion for health equity and an advocate for gender equity and this is reflected not only in her research outputs but in her approach to building the capacity of new researchers. Her supportive approach is highly effective; her students and mentees achieve remarkable success in their careers and progress to make substantial contributions to tobacco research and the community in general. She is an inspiring role model (her young female ECR twitter followers refer to her as their "research idol") not only for productivity and achieving career goals, but also for showing them how to ensure their research makes a meaningful difference to people's lives. Evidence of the effectiveness of her mentoring is in the metrics: she has supervised 19 students, 15 of those PhD students, all on PhD scholarships, and 7 winning awards for PhD excellence from their institutions (University of Newcastle, Monash) or national awards (eg, Council of Australian Public Health Institutions, Cancer Institute NSW)."

 The Mentor Award recognises an individual who has made an important contribution to mentoring and supporting the career development of clinicians, researchers or students.
 
 
 

2019 APSAD Award Highlights

The APSAD Conference and Awards Dinner was held at the Brooke Street Pier situated on Sullivans Cove in the waterfront area of Hobart. 

APSAD President Professor Michael Farrell presented the 2019 APSAD Awards for Excellence in Science, Research and Practice. The recipients of the APSAD Awards are recognised as having made an outstanding contribution to reducing the harms associated with alcohol and other drug use in Australasia. It is a special experience to formally acknowledge the dedication of our peers and celebrate the quality of their work.

APSAD Award Winners with APSAD President 
Left to Right: Michael Farrell (President); Catherine Quinn; Michael Doyle; Emmanuel Kuntsche (back); 
Kate Conigrave; Adrian Dunlop (back); Mark Montebello
 
 
Senior Scientist Award Prof Adrian Dunlop
Professor Adrian Dunlop has over 24 years experience as an addiction clinician and clinician/researcher, he currently serves as the Director and Addiction Medicine Senior Staff Specialist with Hunter New England Local Health District, Drug & Alcohol Clinical Services (2007-current). He is a Conjoint Professor with the School of Medicine and Public Health, University of Newcastle and a member of the Centre for Translational Neuroscience and Mental Health, University of Newcastle and Hunter Medical Research Institute. He was the Chief Addiction Medicine Specialist (2014 – 2018) for the Centre for Population Health, NSW Ministry of Health.
 
The Senior Scientist Award is for a scientist who has made an outstanding contribution to the field of substance use and misuse.
 
Mid Career Award A/Prof Emannuel Kuntsche
Professor Emmanuel Kuntsche has been trained in Psychology (University of Jena, Germany), Sociology (University of Jena, Germany), Public Health (University of Maastricht, the Netherlands) and Statistics (University of Essex, UK). After having mainly worked at Addiction Switzerland, an NGO located in Lausanne, he became a Professor of Public Health at La Trobe University, Melbourne, and the Director of the Centre for Alcohol Policy Research in 2017. He continues his part-time position as an Associate Professor of Developmental Psychopathology at the University of Nijmegen (the Netherlands) and as an Honorary Professor at the Institute of Psychology, Eötvös Loránd University, Budapest, Hungary.
 
The Mid Career Award is for significant contribution in the alcohol and other drug field.
 
Early Career Award Dr Catherine Quinn
Dr Catherine Quinn graduated with a Combined PhD and Clinical Masters in Psychology from Macquarie University in 2015. She currently holds an industry-funded Lives Lived Well Research Fellowship at the School of Psychology, University of Queensland and is a registered clinical psychologist. Dr Quinn is currently working closely with Lives Lived Well, a large alcohol and other drug treatment service, examining the efficacy of novel evidence-based interventions across community and residential treatment settings and the factors that impact their effective implementation. 
 
The Early Career Award is for excellence in research relative to career opportunities.
 
Mentor Award Prof Kate Conigrave
Kate is an Addiction Medicine Specialist and Public Health Physician based at Royal Prince Alfred Hospital. Her work combines treating individuals with alcohol, drug and tobacco problems; promoting the health of communities; and research and teaching.  Kate teaches a wide range of health professional students, including in medicine and public health. She provides clinical training sessions to practising health professionals, including doctors and Aboriginal drug and alcohol professionals. Kate is an editor of two practical texts: Addiction Medicine" (now in its 2nd edition), a guide for doctors and other health professionals; and the "Handbook of Aboriginal Drug and Alcohol Work", written for Aboriginal and Torres Strait Islander health professionals.
 
 The Mentor Award recognises an individual who has made an important contribution to mentoring and supporting the career development of clinicians, researchers or students.
 
First Peoples Award Dr Michael Doyle
Michael is a Bardi person and Wingara Mura Research Fellow at the University of Sydney. Michael began his health career when he enrolled into the Aboriginal Health Worker training program in the Kimberley, while working in the general store of his home community of Djarindjin in 1997. Since then, Michael has worked in men’s health in the Aboriginal community controlled sector in Western Australia. He was worked for the Aboriginal Health Council of Western Australia and helped establish the peak body for Aboriginal community controlled health services in that state. Michael continues to work closely with colleagues in the Aboriginal community-controlled health sector. This includes serving as a member of the Aboriginal Health and Medical Research Council of NSW Human Research Ethics Committee. Michael has worked in research on alcohol and other drugs since 2008, including at the National Drug Research Institute, the Kirby Institute at the University of New South Wales. Since 2017 Michael has worked at the University of Sydney in the Centre of Research Excellence in Indigenous Health and Alcohol.
 
Recognises an individual that has made an important contribution to the advancement of the health of Aboriginal, Torres Strait Islander and Māori peoples.
 
Clinician Award Dr Mark Montebello 
Dr Mark Montebello is an Addiction Medicine Specialist and Addiction Psychiatrist who has been a key mentor for doctors participating in postgraduate drug and alcohol medicine in NSW and across Australia. He has been the Director of Advanced Training in Addiction Psychiatry for the RANZCP, has been Chair of the Training Committee of the Chapter of Addiction Medicine RACP, is a Conjoint Senior Lecturer with the University of New South Wales and University of Sydney, and is Clinical Director for Drug and Alcohol Services for North Sydney Local Health District.   
 
Recognises excellence and leadership in clinical practice in the field of substance use in any discipline.
 
 

APSAD Awards for Excellence in Science, Research & Practice

APSAD Awards Banner

Nominations are now being sought for the 18th APSAD Awards for Excellence in Science, Research, & Practice

2019 APSAD Award Winners

APSAD is pleased to confirm that the 2021 Annual Awards for Excellence in Science, Research, & Practice is calling for nominations. The Awards will be presented in Brisbane at the 40th APSAD Conference in November.

Australia's leading multidisciplinary organisation for professionals involved in the drug and alcohol field, these prestigious Awards are our unique celebration of the outstanding efforts and achievements of individuals and teams who provide devoted and unstinting service to their communities in diverse fields and go unrecognised.

Acknowledging dedication and excellence in our sector is a key part of the APSAD Awards, as well as encouraging future generations of great researchers and clinicians.

The Awards are nominated by APSAD’s members and decided by the APSAD Awards Subcommittee. The recipients of the Early Career and Advocacy Awards will be announced in October 2021.

The Recipients for all 2021 Awards Categories will be announced at the official Awards Ceremony held during the 40th APSAD Conference in Brisbane 7-10 November,

We are excited to announce that in line with the Society's 40th Anniversary we have added the new Advocacy Award, to recognise the outstanding impact by an individual or a team in the alcohol, tobacco, and other drugs sector who works in the policy and/or advocacy area.

Download the Information Pack and the Nomination Form.

All seven APSAD Awards reflect excellence in the application of theory, knowledge and practice to any aspect of drug and alcohol use.

Focus of the Awards:

The Early Career Award is for excellence in research relative to career opportunities.

The Mid Career Award is is for significant contribution in the alcohol and other drug field.

The Senior Scientist Award is for a scientist who has made an outstanding contribution to the field of substance use.

The First Peoples Award recognises an individual that has made an important contribution to the advancement of the health of Aboriginal, Torres Strait Islander and Māori peoples.

The Clinician Award recognises excellence and leadership in clinical practice in the field of substance use in any discipline.

The Mentor Award recognises an individual who has made an important contribution to mentoring and supporting the career development of clinicians, researchers or students.

The Advocacy Award recognises the outstanding impact by an individual or a team in the alcohol, tobacco, and other drugs sector who works in the policy and/or advocacy area.

Please contact Liz Baxter at the APSAD Office on (02) 9252-2287 or by email This email address is being protected from spambots. You need JavaScript enabled to view it. if you require further information.

 

APSAD on YouTube

write paper for me